Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Entera Bio Ltd. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −2 vs. Q1 2022
- Shares held
- 4.92M
- −33.2K (−0.7%) vs. Q1 2022
- Total value
- $6.54M
- −$7.67M (−54.0%) vs. Q1 2022
- New holders
- 0
- 1 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,275 | $3.30M | 1.89% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,353,000 | $3.13M | 0.08% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,597 | $23.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 16,865 | $22.0K | 0.00% | −29,344−63.5% | Reduced |
| Citadel Advisors LLC | 12,657 | $17.0K | 0.00% | −2,400−15.9% | Reduced |
| Altium Wealth Management LLC | 11,830 | $16.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,404 | $10.0K | 0.00% | +2,744+58.9% | Added |
| Morgan Stanley | 2,766 | $4.00K | 0.00% | −2,190−44.2% | Reduced |
| Royal Bank of Canada | 576 | $1.00K | 0.00% | −5−0.9% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −1,744−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −230−100.0% | Sold out |